ICAM1 and neoplasm: For instance, exosomes derived from dendritic cells or macrophages can be engineered to express ligands that target receptors overexpressed on tumor cells, such as LFA-1 or ICAM-1, further improving the specificity of drug delivery (Guo and Jiang, 2020; Zhang W. et al., 2022).